Neuroprotective effects of TNF binding protein in focal cerebral ischemia

Brain Research

Volumn 778, Issue 2, 1997, Pages 265-271

  Nawashiro, Hiroshi ^a   Martin, David ^b   Hallenbeck, John M ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b AMGEN INC   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Brain infarction; DNA fragmentation; Mouse; TNF binding protein; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR BINDING PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DNA DEGRADATION; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BIOTIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DEOXYURACIL NUCLEOTIDES; DNA FRAGMENTATION; FREE RADICAL SCAVENGERS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MICE; MICE, INBRED BALB C; NEURONS; NEUROPROTECTIVE AGENTS; NITROGEN OXIDES; PHOSPHOPYRUVATE HYDRATASE; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIALOGLYCOPROTEINS; STAINING AND LABELING; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031578934     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00981-5     Document Type: Article

References (23)

1. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor α. A mediator of focal ischemic injury. Stroke. 28:1997;1233-1244.
2. + T cell infiltration. J. Immunol. 149:1992;2954-2960.
3. Buttini M., Appel K., Sauter A., Gebicke-Haerter P.J., Boddeke H.W.G.M. Expression of tumor necrosis factor alpha after focal cerebral ischemia in the rat. Neuroscience. 71:1996;1-16.
4. Cao X., Phillis J.W. α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 644:1994;267-272.
5. Dawson D.A., Martin D., Hallenbeck J.M. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci. Lett. 218:1996;1-4.
6. Donato N.J., Ince C., Rosenblum M.G., Gallick G.E. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation. J. Cell Biochem. 41:1989;139-157.
7. Dong H.D., Kimoto Y., Takai S., Taguchi T. Apoptosis as a mechanism of lectin-dependent monocyte-mediated cytotoxicty. Immunol. Invest. 25:1996;65-78.
8. Feuerstein G.Z., Lie T., Barone F.C. Cytokines, inflammation, and brain injury: role of tumor necrosis factor α Cerebrovasc. Brain Metab. Rev. 6:1994;341-360.
9. Garcia J.H., Liu K.F., Relton J.K. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol. 147:1995;1477-1486.
10. 2 and TRADD-FADD interactions define two distinct TNF receptor I signal transduction pathways. Cell. 84:1996;299-308.
11. Li Y., Chopp M., Jiang N., Yao F., Zaloga C. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 15:1995;389-397.
12. Lin T.N., He Y.Y., Wu G., Khan M., Hsu C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 24:1993;117-121.
13. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., Feuerstein G.Z. Tumor necrosis factor α expression in ischemic neurons. Stroke. 25:1994;1481-1488.
14. Martin D., Near S.L., Bendele A., Russell D.A. Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein. Exp. Neurol. 131:1995;221-228.
15. Memezawa H., Smith M.L., Siesjö B.K. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke. 23:1992;552-559.
16. Mokuno K., Ohtani K., Suzumura A., Kiyosawa K., Hirose Y., Kawai K., Kato K. Induction of manganese superoxide dismutase by cytokines and lipopolysaccharide in cultured mouse astrocytes. J. Neurochem. 63:1994;612-616.
17. Nawashiro H., Martin D., Hallenbeck J.M. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J. Cereb. Blood Flow Metab. 17:1997;229-232.
18. Relton J.K., Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29:1992;243-246.
19. Relton J.K., Martin D., Russell D. Interleukin-1 receptor antagonist inhibits ischemic brain damage in the rat. Soc. Neurosci. 19:1993;6732.
20. Suzuki K., Tatsumi H., Satoh S., Senda T., Nakata T., Fujii J., Taniguchi N. Manganese-superoxide dismutase in endothelial cells: localization and mechanism of induction. Am. J. Physiol. 265:1993;H1173-H1178.
21. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10:1990;290-293.
22. Tureen J. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide. J. Clin. Invest. 95:1995;1086-1091.
23. Welsh F.A., Sakamoto T., McKee A.E., Sims R.E. Effects of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain. J. Neurochem. 49:1987;846-851.